Sally Arai
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Blood & Marrow Transplantation
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Blood and Marrow Transplant Program 300 Pasteur Drive H0101, MC 5623 Stanford, CA 94305 Tel Work (650) 723-0822 Fax (650) 725-8950
- Academic Offices
Personal Information Email Tel (650) 723-0822Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Blood and Marrow Transplant
- Hematology
- Blood and Marrow Transplantation
Honors and Awards
- K23-Reduce GVHD and Relapse using Ex-Vivo Expanded Allogeneic Cell Therapy, NIH (2003-2008)
- A phase I/II study of post-transplant autologous CIK cells for high-risk hematologic malignancies, Cancer Treatment Research Foundation (2005-2009)
Professional Education
| Fellowship: | John Hopkins Hospital MD (1999) |
| Fellowship: | Mount Sinai Medical Center NY (1998) |
| Internship: | Strong Memorial Hospital NY (1993) |
| Medical Education: | Dartmouth Medical School NH (1991) |
| MS: | Stanford University, Epidemiology (2006) |
| MD: | Dartmouth Medical School |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
Clinical Trials
- Recruiting TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
- Recruiting Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
- Recruiting Bone Marrow Grafting for Leukemia and Lymphoma
- Not Recruiting Transplantation for Patients With Chronic Lymphocytic Leukemia
- Recruiting Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic Malignancies
Publications
- H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease. Proc Natl Acad Sci U S A. 2013; (8): 3005-10
- The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. Br J Haematol. 2013; (3): 367-72
- Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. J Heart Lung Transplant. 2012; (3): 325-31
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood. 2012; (25): 6145-54
- Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Bone Marrow Transplant. 2012; (4): 581-8
- A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood. 2011; (15): 4070-8
Help
Trial Administration